Menu
Recruiting NCT06852547

The Effect of Ingesting a Novel Algae Protein Source on Rested and Exercised Muscle Protein Synthesis Rates in Older Adults.

No phase Interventional Nutritional Intervention

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: protein.
Who it may be relevant to
Registry conditions: Nutritional Intervention. Basic parameters: 65 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Ingestion of a Novel Algae Protein Source on Rested and Post Exercise Muscle Protein Synthesis Rates.

Overview

To assess the rested and postexercise muscle protein synthetic response following the ingestion of a flavourless algae protein source compared with whey protein in older adults.

Interventions

  • Dietary supplement protein
    protein

Primary outcome measures

  • Postprandial muscle protein synthesis [Time frame: 4 hours]

Eligibility criteria

Inclusion criteria

Males and Females BMI 18.5 - 30 kg/m2 Aged 65-80 years Recreationally Active

Exclusion criteria

Body mass index (BMI) <18.5 or >30 kg/m2 Any metabolic impairments Any cardiovascular impairments High blood pressure (≥140/90 mmHg) Any gastrointestinal disorders Any medications known to affect protein and/or amino acid metabolism A personal or family history of epilepsy, seizures or schizophrenia, motor disorder Chronic over the counter use of pharmaceuticals (> 1 month) Allergic to any of the whole foods included in the study

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Double blind
Primary purpose
Other

Study locations

United Kingdom · 1 center
  • Health and Life Sciences — Exeter

Identifiers

NCT: NCT06852547 · 9071916

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗